Rolling Stone

Sombr Takes on Phoebe Bridgers’ ‘Motion Sickness’ for BBC Radio 1 Piano Session

Sombr dug through Phoebe Bridgers’ emotional wreckage with a cover of “Motion Sickness” for BBC Radio 1. The 20-year-old crooned the melancholic record backed solely by a solemn piano melody. “It’s ...
Uproxx

Sombr Turns In A Powerful Piano Cover Of Phoebe Bridgers’ ‘Motion Sickness’

After emerging as one of 2025’s biggest breakout stars, Sombr’s 2026 is off to a good start. Over the weekend, he dropped by BBC Radio 1 for a “Piano Sessions” performance. For his song, he, joined by ...
Everyday Health

There’s a New Drug for Motion Sickness — the First in 40 Years

The FDA approved a new pill called Nereus (tradipitant) that can prevent vomiting caused by motion sickness. In clinical trials, Nereus helped up to 90 percent of people prone to motion sickness avoid ...
Acsh.org

The First New Motion-Sickness Drug in 40 Years: Hi-Ho, or Heave-Ho?

Does motion sickness turn you into a green, spewing mess? For plenty of people, the answer is yes. Current remedies may or may not help. But after 40 years, the first new motion-sickness drug has been ...
Monthly Prescribing Reference

FDA Approves Novel Motion Sickness Treatment Nereus

In clinical trials, the incidence of vomiting was significantly lower with tradipitant compared with placebo during boat trips. The Food and Drug Administration (FDA) has approved Nereus™ (tradipitant ...
New Atlas

First new motion sickness drug arrives after nearly half a century

Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) approving a novel oral pill that helps prevent motion-induced vomiting – the first ...
WebMD

Nereus: FDA Approves New Pill to Help With Motion Sickness

What Is Nereus, And Why Does It Matter? Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such ...
MedPage Today

FDA Greenlights First Motion Sickness Drug in More Than 40 Years

The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday. The approval marks the ...
Yahoo

FDA approves Vanda Pharmaceuticals’ motion sickness drug Nereus

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals’ Nereus (tradipitant) for the prevention of vomiting ...
Becker's Hospital Review

FDA approves 1st motion sickness drug in over 40 years

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...
Reuters

US FDA approves Vanda Pharmaceuticals' motion sickness drug

Dec 30 (Reuters) - Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health regulator, becoming the first ...